Four Early-Stage Antibacterial Drugs To Watch: Highlights From IDWeek

Promising drugs from Tetraphase, ContraFect, Spero and Entasis get a platform at the Infectious Diseases Society of America’s IDWeek.

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,

During its annual IDWeek, held Oct. 3-7 in San Francisco, the Infectious Diseases Society of America put the spotlight on the antibiotic pipeline, highlighting the following drugs making their way through the development and registration processes:

TetraPhase Pharmaceuticals Inc.is advancing its TP-6076 antibiotic, a novel tetracycline, after reporting Phase I data.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category